Insmed

-$0.41 (-1.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insmed and other ETFs, options, and stocks.

About INSM

Insmed, Inc. is a biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Its first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options.

CEO
William H. Lewis
Employees
521
Headquarters
Bridgewater, New Jersey
Founded
1988

INSM Key Statistics

Market Cap
3.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
857.56K
High Today
$27.38
Low Today
$26.44
Open Price
$27.38
Volume
640.43K
52 Week High
$45.44
52 Week Low
$22.00

INSM Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure